|
|
Index of Articles From 1997 Taglines
- December, 1997
- The Worldwide Epidemic: Global AIDS Picture Worsens
- Global Infectious Causes of Death (Table)
- The Future of AIDS (Table)
- The Twilight of Eradication: Infectious HIV Persists After Up to 2 1/2 Years of Triple Drug Therapy
- November, 1997
- The FDA Decides the Fate of Two Drugs for AIDS-Related Malignancies
- Three New Antivirals Trickle From the Pipeline
- Hamburg Highlights
- October, 1997
- Republicans and Pharmaceutical Industry Target the FDA
- Low Key Dual Combo Appears First to Achieve the Unimaginable
- September, 1997
- Would-Be Eradicatee Looks Forward to Still Uncertain Future
- Data from the 23rd ACTG Meeting Document Reduction in Number of Opportunistic Infections in the Era of HAART
- The Opportunistic Infections of ACTG 320 (Table)
- August, 1997
- Roche Racks Up Millions In Early Saquinavir Sales While Unwitting Patients Prime Themselves for Protease X-Resistance
- Metabolic Disturbances in HIV Infection Find Friend Not Foe in Protease Inhibitor Regimens
- How the Triple Combos Stack Up (Table)
- June/July, 1997
- May, 1997
- April, 1997
- March, 1997
- February, 1997
- January, 1997
Back to the Treatment Action Group index page
|
|
